MarketCapExport financials
Broadway Financial Corporation (BYFC)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Broadway Financial Corporation Financial Ratios 2025-2009 | BYFC
Brief overview of Broadway Financial Corporation's financial ratios
The comparison uses the five latest available annual observations between 2017 and 2024.
Market valuation is represented by P/E 31.44x (median 31.44x), P/B 0.24x (median 0.21x), P/CF 271.31x (median 43.54x). Current valuation broadly matches recent historical reference points; the difference from five-year medians is +11.6%.
Current earnings relative to valuation equal about 3.2% on the 1/P/E measure. This is a valuation reference, not an expected payout.
Returns on assets and capital are represented by ROE -9.4%, ROA -1.8%. Returns below zero mean resources are not producing positive profit. Recovery in operating results is the main reference point.
PEG of 0.63x shows valuation is not outpacing embedded growth. The conclusion depends on earnings durability.
For this sector, valuation ratios are useful only alongside capital adequacy, reserves and credit-portfolio quality.
Conclusion
Broadway Financial Corporation's multiples form a balanced picture without a clear discount or premium. Future appeal depends on earnings and return trends.
Annual Financial Ratios Broadway Financial Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-2.5 | 31.4 | 9.4 | 1.7 | -34.3 | -86.1 | -204.5 | 45.3 | 34.8 | 12.9 | 4.8 | 9.8 | -78.6 | 3.1 | -0.3 | 26.4 | - |
P/S |
339.1 | 391.3 | 227.5 | 64.3 | 558.0 | 3.1 | 3.7 | 3.4 | 5.0 | 3.6 | 3.1 | 2.0 | 2.0 | 0.1 | 0.1 | - | - |
EPS |
-3.2 | 0.0 | 0.3 | 0.6 | -0.1 | -0.0 | -0.0 | 0.0 | 0.1 | 0.1 | 0.3 | 0.1 | -0.1 | -0.4 | -8.8 | 0.4 | - |
EV (Enterprise Value) |
1.13 B | 1.05 B | 1.06 B | 898 M | 860 M | 394 M | 418 M | 381 M | 409 M | 410 M | 333 M | 318 M | 272 M | 293 M | 366 M | 480 M | -7.44 M |
EBITDA per Share |
0.05 | 0.05 | 0.04 | 0.04 | - | -0.0341 | - | - | - | - | - | - | - | - | - | 0.24 | - |
EV/EBITDA |
2767.1 | 2474.0 | 2753.9 | 2387.9 | 2931.0 | 17.1 | - | - | - | - | - | - | - | - | - | 1128.5 | - |
PEG |
- | - | - | - | - | 0.63 | 1.54 | -0.8 | -0.84 | -0.21 | 0.03 | 0.05 | -1.19 | 0.03 | 0.0 | - | - |
P/B |
0.2 | 0.2 | 0.1 | 0.0 | 1.0 | 1.1 | 0.9 | 0.8 | 1.4 | 1.0 | 0.9 | 0.7 | 0.9 | 0.1 | 0.1 | 1.5 | - |
P/CF |
271.3 | 43.5 | 5.4 | 1.5 | 222.7 | -4.0 | 5.0 | 235.2 | -6.3 | 58.4 | 3.1 | 22.6 | 17.6 | 0.6 | 0.4 | 4.6 | - |
ROE % |
-9.44 | 0.68 | 1.54 | 2.02 | -2.87 | -1.31 | -0.42 | 1.68 | 3.92 | 7.64 | 19.65 | 6.79 | -1.18 | 3.27 | -41.35 | 5.83 | - |
ROA % |
-1.84 | 0.14 | 0.31 | 0.48 | -0.37 | -0.13 | -0.05 | 0.20 | 0.45 | 0.81 | 2.25 | 0.72 | -0.09 | 0.16 | -2.27 | 0.40 | - |
Current Ratio |
1.2 | 1.3 | 1.3 | 1.3 | 1.1 | - | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.1 | - |
DSO |
10910.3 | 11702.4 | 9085.2 | 9244.6 | 3352.4 | 7450.0 | 39.3 | 37.9 | 29.9 | 34.5 | 27.7 | 36.5 | 33.6 | 32.4 | 34.9 | - | - |
Operating Cycle |
10910.3 | 11702.4 | 9085.2 | 9244.6 | 3352.4 | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
10910.3 | 11702.4 | 9085.2 | 9244.6 | 3352.4 | - | - | - | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Financial Ratios Broadway Financial Corporation
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | 0.05 | - | -2.86 | - | -0.3 | 0.16 | -0.03 | 0.03 | -0.02 | - | 0.01 | 0.03 | 0.18 | - | 0.14 | 0.03 | 0.01 | - | - | 0.01 | -0.13 | - | -0.01 | 0.01 | - | - | -0.01 | -0.01 | 0.01 | - | 0.03 | - | - | - | 0.02 | 0.02 | 0.05 | - | 0.01 | 0.01 | 0.02 | - | 0.03 | 0.04 | 0.04 | - | 0.04 | - | 0.05 | - | 0.05 | -0.29 | -0.49 | - | -0.48 | 0.81 | -0.08 | - | -4.47 | -1.15 | -0.24 |
EBITDA per Share |
0.01 | 0.01 | - | 0.01 | 0.02 | 0.01 | - | 0.01 | 0.01 | 0.02 | - | 0.01 | 0.01 | 0.02 | - | 0.01 | - | - | - | - | - | - | - | 0.01 | - | 0.01 | - | 0.01 | - | - | - | 0.01 | - | - | - | 0.01 | - | - | - | 0.01 | - | - | - | 0.01 | - | - | - | 0.01 | 0.01 | - | - | 0.04 | 0.06 | 0.03 | - | 0.13 | 0.09 | 0.04 | - | 0.18 | 0.12 | 0.06 |
ROE % |
-8.42 | -9.07 | -9.52 | -9.02 | 0.29 | 0.12 | 0.72 | 0.25 | 0.16 | 0.62 | 0.68 | 1.16 | 1.78 | 2.39 | 1.83 | 1.96 | 1.97 | -6.42 | -7.12 | -7.62 | -7.30 | -7.86 | -0.12 | -0.70 | -0.47 | -0.35 | -0.28 | 1.27 | 1.58 | 1.68 | 1.11 | 2.17 | 1.73 | 4.58 | 4.75 | 5.47 | 5.12 | 5.39 | 2.81 | 4.93 | 6.71 | 8.82 | 7.43 | 9.48 | 7.52 | 7.68 | 4.87 | 7.15 | 4.20 | 1.64 | -1.02 | -4.42 | 2.72 | 4.47 | 6.88 | -34.35 | -40.37 | -50.50 | -51.35 | -41.22 | -9.42 | -0.71 |
ROA % |
-1.65 | -1.80 | -1.88 | -1.77 | 0.06 | 0.02 | 0.16 | 0.05 | 0.03 | 0.15 | 0.16 | 0.27 | 0.41 | 0.48 | 0.35 | 0.37 | 0.32 | -0.56 | -0.64 | -0.69 | -0.67 | -0.74 | -0.01 | -0.08 | -0.06 | -0.04 | -0.03 | 0.15 | 0.18 | 0.19 | 0.13 | 0.25 | 0.20 | 0.53 | 0.55 | 0.62 | 0.58 | 0.60 | 0.30 | 0.54 | 0.75 | 1.00 | 0.85 | 1.07 | 0.84 | 0.84 | 0.52 | 0.69 | 0.41 | 0.20 | -0.08 | -0.24 | 0.04 | 0.15 | 0.33 | -1.49 | -1.74 | -2.23 | -2.27 | -1.82 | -0.42 | -0.03 |
Current Ratio |
1.2 | 1.2 | 1.3 | 1.2 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | - | 1.3 | 1.3 | 1.1 | 1.1 | 1.2 | 1.2 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 |
DSO |
14104.8 | 12108.2 | - | 10443.3 | 11943.7 | 10443.9 | - | 13905.5 | 13046.4 | 10962.5 | - | 9819.1 | 10005.1 | 3155.6 | - | 13385.5 | 11173.8 | 4149.7 | - | 3083.9 | 4726.0 | 1157.3 | - | 1179.4 | 1166.8 | 768.3 | - | 962.1 | 970.4 | 884.8 | - | 948.2 | 939.6 | 879.2 | - | 836.9 | 979.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | 10943.2 | - | 12062.0 | - | 13905.5 | 13046.4 | 12048.4 | - | 9819.1 | 10005.1 | 3155.6 | - | 13385.5 | 11173.8 | 4149.7 | - | 3083.9 | 4726.0 | 1157.3 | - | 1179.4 | 1166.8 | 768.3 | - | 962.1 | 970.4 | 884.8 | - | 948.2 | 939.6 | 879.2 | - | 836.9 | 979.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | 10943.2 | - | 12062.0 | - | 13905.5 | 13046.4 | 12048.4 | - | 9819.1 | 10005.1 | 3155.6 | - | 13385.5 | 11173.8 | 4149.7 | - | 3083.9 | 4726.0 | 1157.3 | - | 1179.4 | 1166.8 | 768.3 | - | 962.1 | 970.4 | 884.8 | - | 948.2 | 939.6 | 879.2 | - | 836.9 | 979.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Multiples are an important financial analysis tool for the company Broadway Financial Corporation, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
USA
India
